Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gastrointestinal 1

Conditions

Weight Loss 1Pancreatic Neoplasms 1Malnutrition 1Lung Neoplasms 1Head and Neck Neoplasms 1Body Weight 1

Interventions

Cyclophosphamide 222pembrolizumab 201Carboplatin 173Cisplatin 168Gemcitabine 167Paclitaxel 155Docetaxel 140Bevacizumab 138Rituximab 137Radiotherapy 137Nivolumab 126Dexamethasone 126Capecitabine 103fludarabine 102Pemetrexed 92fludarabine phosphate 91Fluorouracil 91Doxorubicin 85Oxaliplatin 79Etoposide 77Cytarabine 77Bortezomib 76Erlotinib Hydrochloride 74Leucovorin 72Filgrastim 68Lenalidomide 67Calcium Dobesilate 66Irinotecan 65atezolizumab 63Radiation 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Has results × Mirtazapine × Clear all
NCT04155008 2022-11-16

Nutrition and Pharmacological Algorithm for Oncology Patients Study

Montefiore Medical Center

Phase 4 Terminated
1 enrolled 5 charts
GastrointestinalHead & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Malnutrition

NCT00832520 2018-04-10

Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight

New Mexico Cancer Research Alliance

Phase 2 Terminated
13 enrolled 4 charts

Body Weight, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡